Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc. | 0 | 25 | 0 | 2 | €0.37 | - | - |
| Moleculin Biotech Inc | 3 | 25 | 0 | 3 | €0.41 | €18.42 | 4393.659% |
| Trevena Inc. | 2 | 23 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
| AEterna Zentaris Inc. | 2 | 22 | 0 | 2 | €1.87 | €8.51 | 355.096% |
| Novan Inc | 0 | 20 | 0 | 0 | €0.001 | - | - |
| InVivo Therapeutics Holdings | 0 | 13 | 0 | 0 | €0.31 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | €0.064 | - | - |
| Minerva Neurosciences Inc. | 0 | 10 | 0 | 1 | €2.50 | - | - |
| Mirati Therapeutics Inc. | 1 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
| Organovo Holdings Inc. | 0 | 9 | 0 | 1 | €0.55 | - | - |
| Waters Corp. | 0 | 6 | 0 | 0 | €309.00 | €265.52 | -14.070% |
| Cyclacel Pharmaceuticals Inc. | 2 | 8 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
| Glycomimetics Inc. | 3 | 7 | 0 | 4 | €0.15 | €9.13 | 5997.864% |
| T2 Biosystems Inc. | 0 | 4 | 0 | 0 | €0.16 | - | - |
| Nevro Corp. | 1 | 4 | 0 | 1 | €5.50 | €13.77 | 150.380% |
| Integra LifeSciences Holdings Corp | 3 | 6 | 0 | 2 | €18.30 | €31.62 | 72.762% |
| Cardiff Oncology Inc. | 2 | 4 | 0 | 0 | €2.09 | €5.00 | 139.234% |
| Bayer AG ADR | 0 | 2 | 0 | 1 | €6.75 | - | - |
| Coherus Bioscien. | 0 | 2 | 0 | 0 | €1.20 | - | - |
| Immuron | 0 | 1 | 0 | 0 | €2.30 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Fibrogen Inc. | 0 | 1 | 0 | 0 | €0.31 | - | - |
| NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.50 | - | - |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €7.00 | €58.50 | 735.714% |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |